Clinical Trial Update: NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients [Phase 2]

View source ↗

Summary

A Phase II randomized, double-blind, placebo-controlled trial assessed the effects of N-acetylcysteine on redox changes and lung inflammation in cystic fibrosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Stanford University | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2013-03-15